The Rosen Law Firm Files Securities Fraud Class Action Charging Zynex, Inc. f/k/a Zynex Medical Holdings, Inc. With Violations of the Federal Securities Laws

NEW YORK, NY--(Marketwire - April 7, 2009) - The Rosen Law Firm today announced that it has filed a securities fraud class action lawsuit on behalf of all purchasers of Zynex, Inc. (OTCBB: ZYXI) formerly known as Zynex Medical Holdings, Inc. (OTCBB: ZYNX) (collectively "Zynex" or the "Company") securities between May 21, 2008 and March 31, 2009 inclusive (the "Class Period").

To join the Zynex class action, go to the website at http://www.rosenlegal.com or call Laurence Rosen, Esq. or Phillip Kim, Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com or pkim@rosenlegal.com for information on the class action.

The case is pending in the United States District Court for the District of Colorado as case no. 09-CV-780. You can obtain a copy of the complaint from the clerk of court or you may contact counsel for plaintiffs Laurence Rosen, Esq. or Phillip Kim, Esq. toll-free at 866-767-3653 or email lrosen@rosenlegal.com or pkim@rosenlegal.com.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER. YOU MAY ALSO RETAIN COUNSEL OF YOUR CHOICE.

The Complaint charges Zynex, its CEO Sandgaard, and CFO Allison (the "Defendants") with violations of the Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 in connection with Zynex's issuance of materially false financial statements to the investing public during the Class Period. According to the Complaint, the Defendants, in violation of the Generally Accepted Accounting Principles and Zynex's own internal polices, misstated the Company's reported net revenues and accounts receivable for the first three quarters of fiscal 2008.

On April 1, 2009 Zynex announced that its unaudited financial statements and press releases issued on results for the first three quarters of 2008 can no longer be relied upon and would have to issue restated financial results to reflect adjustments to accounts receivable and net revenue for such periods. The Company announced that it believed the cumulative impact of these adjustments would be $5.1 million. This adverse news caused Zynex's stock price to fall dramatically, injuring Zynex shareholders.

A class action lawsuit has already been filed on behalf of Zynex shareholders. If you wish to serve as lead plaintiff, you must move the Court no later than June 8, 2009. If you wish to join the litigation or to discuss your rights or interests regarding this class action, please contact plaintiff's counsel, Laurence Rosen, Esq. or Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at lrosen@rosenlegal.com or pkim@rosenlegal.com.

The Rosen Law Firm represents investors throughout the United States, concentrating its practice in securities class actions and shareholder derivative litigation.